-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Surgery Partners, Lowers Price Target to $19

Benzinga·08/11/2026 15:32:52
Listen to the news
RBC Capital analyst Ben Hendrix maintains Surgery Partners (NASDAQ:SGRY) with a Outperform and lowers the price target from $20 to $19.